Janet VasquezPR

@Janetvasquezpr

Founder, JV Public Relations NY. PR veteran specializing in pharma, life sciences, health & wellness, medical devices and biotech sectors. [email protected]

Metro New York
הצטרף/ה ב-דצמבר 2011

@Janetvasquezpr חסומ/ה

האם אתה בטוח שאתה מעוניין להציג ציוצים אלה? הצגת הציוצים לא תשחרר את החסימה של ‎@Janetvasquezpr.

  1. צייצת מחדש

    Now at : Adaptive pathways & early market access roundtable, feat

  2. Denis Corin from Q BioMed talks to The Bio Connection:

  3. Q&A with Denis Corin, Q Bio Med Inc – Getting Past the “Pharma Bro” – Smaller Biotech Continue to Strive for Well-Be…

  4. Called Off: Pharmaceutical Giants Pfizer and Allergan to abandon $212 billion merger

  5. My thanks to Fred Fishkin for chatting with Labstyle's Todd Durniak on today's broadcast of Bootcamp Radio: . Great…

  6. Janet VasquezPR עקב אחרי , , ו־
    • @ImageIQ

      Innovative imaging contract research services for preclinical research, clinical trial management & product development. A Innovations Company.

    • @jillroselim

      Canadian health & wellness writer. Editorial Manager . NYU , alum. Love hiking, coffee, books, & all things mindfulness. Views my own.

  7. The entire Pluristem team welcomes Japanese Ambassador, Koji Tomita to our labs in Haifa, Israel

  8. Actinium Announces Webinar to Discuss SIERRA Trial -- Upcoming Pivotal, Phase 3 Clinical Study for Iomab-B:

  9. Pluristem Therapeutics' CEO Zami Aberman welcomes Japanese Ambassador Koji Tomita to Pluristem's labs in Haifa, Isra…

  10. Happy to share a photo of the Pluristem Therapeutics team welcoming Japanese Ambassador, Koji Tomita to its Haifa, I…

  11. Mark your Calendars! Sign up to join Actinium's webinar to discuss SIERRA trial on Tuesday, April 26 at 8:30 AM!

  12. Pluristem CEO Zami Aberman welcomes Japanese Ambassador, Koji Tomita to Haifa labs

  13. Actinium Pharmaceuticals, Inc.'s Iomab-B news featured in Clinical Oncology News

מסתבר כי הטעינה לוקחת זמן־מה.

ייתכן שיש עומס או תקלה זמנית בטוויטר. נסה שוב או בקר בדף המצב של טוויטר לקבלת מידע נוסף.

    ייתכן שגם ימצא חן בעיניך

    ·